Skip to content

In the BioHarmony Drug Report Database

Febuxostat

Uloric, Adenuric (febuxostat) is a small molecule pharmaceutical. Febuxostat was first approved as Uloric on 2008-04-21. It is used to treat gout in the USA. It has been approved in Europe to treat gout, gouty arthritis, and hyperuricemia. The pharmaceutical is active against xanthine dehydrogenase/oxidase. Uloric's patents are valid until 2031-09-08 (FDA).
Trade Name Adenuric
Common Name Febuxostat
Indication gout, gouty arthritis, hyperuricemia
Drug Class Enzyme inhibitors: xanthine oxydase and xanthine
Febuxostat
Get full access now